This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Neurostimulation Industry

8. NEUROSTIMULATION DEVICE APPROVALS II-29

SPR™ Therapeutics' SMARTPATCH™ Neurostimulation System

Obtains FDA's IDE Approval II-29

Bioness Receives FDA Clearance for Use of Smaller Leg Cuff

with L300 Foot Drop System II-29

Imthera Medical's AURA6000 Awarded CE Mark for Sleep Apnea

Therapy II-29

Neuronetics' Magnetic Brain Stimulation Device Receives CE

Approval II-30

St. Jude Medical's Eon Mini Stimulator Obtains European CE

Mark Approval II-30

Boston Scientific's Precision Plus SCS Wins FDA Approval for

Limb Pain II-30

Boston Scientific's Infinion™ 16 Percutaneous Lead Obtains CE

Approval II-30

NeuroSigma Obtains CE Approval for Monarch Nerve Stimulation

System II-31

Neurotech's ADNS-300 Neurostimulation Device Obtains CE Mark

Approval II-31

Bioness Bags FDA Approval for NESS L300 Plus, for Managing

Thigh Weakness II-31

Bioness Obtains CE Mark Approval and FDA Clearance For NESS

H200 Hand Rehabilitation System II-31

Boston Scientific's Clik Anchor Obtains FDA Approval II-32

Medtronic's AdaptiveStim RestoreSensor Lands US FDA Approval II-32

Synapse Biomedical Obtains FDA Approval for NeuRx Diaphragm

Pacing System II-32

St Jude Medical's Genesis System Secures CE Mark Approval II-32

St. Jude Receives Approval for Neurostimulation System from

Japanese MHLW II-33

St. Jude Secures European CE Mark Approval for Epiducer™ Lead

Delivery System II-33

St. Jude Medical Obtains TGA Approval for Brio™ DBS System II-33

Boston Scientific Secures FDA Approval for D4 and W4 SCS Lead

Splitters II-33

St. Jude Medical Receives Approval for Penta Neurostimulation

Lead from FDA II-34

St. Jude Receives European CE Mark Approval for LibraXP™ and

Libra® Deep Brain Stimulation Systems II-34

Medtronic Receives FDA Approval for Activa PC and Activa RC

DBS Devices II-34

Medtronic Receives FDA Approval for Reclaim™ Deep Brain

Stimulation Therapy II-34

St. Jude Receives European CE Mark Approval for Genesis®

Neurostimulation System II-35

St. Jude Eon Mini™ Neurostimulator Receives Australian

Therapeutic Goods Administration Approval II-35

Medtronic Receives FDA Approval for Activa® RC, Activa PC DBS

3 of 11

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs